Detalles de la búsqueda
1.
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 25(5): 626-635, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38697156
2.
Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial.
Hepatology
; 77(5): 1540-1549, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37070950
3.
Real-world efficacy and safety of capecitabine with oxaliplatin in patients with advanced adenocarcinoma of the ampulla of Vater.
BMC Cancer
; 24(1): 634, 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38783256
4.
Impact of COVID-19 Infection and Its Association With Previous Vaccination in Patients With Myasthenia Gravis in Korea: A Multicenter Retrospective Study.
J Korean Med Sci
; 39(18): e150, 2024 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38742290
5.
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study.
Lancet Oncol
; 24(7): 772-782, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37276871
6.
Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer.
Future Oncol
; 19(34): 2277-2289, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37746835
7.
Experience and perspectives of end-of-life care discussion and physician orders for life-sustaining treatment of Korea (POLST-K): a cross-sectional study.
BMC Med Ethics
; 24(1): 18, 2023 03 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36882795
8.
Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial.
Lancet Oncol
; 23(1): 115-124, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34919824
9.
Phase II study of durvalumab monotherapy in patients with previously treated microsatellite instability-high/mismatch repair-deficient or POLE-mutated metastatic or unresectable colorectal cancer.
Int J Cancer
; 150(12): 2038-2045, 2022 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35179785
10.
Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma.
Liver Int
; 42(3): 674-681, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34792284
11.
Prognostic implication of serum AFP in patients with hepatocellular carcinoma treated with regorafenib.
Future Oncol
; 18(27): 3021-3030, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35903991
12.
A structural equation modeling approach to understanding physical function of terminal cancer patients.
Support Care Cancer
; 30(2): 1149-1158, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34435210
13.
Early-Onset Myasthenia Gravis Following COVID-19 Vaccination.
J Korean Med Sci
; 37(10): e50, 2022 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35289135
14.
Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
BMC Cancer
; 21(1): 77, 2021 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33461517
15.
Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study.
BMC Cancer
; 21(1): 1176, 2021 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34732161
16.
The development and validation of a predictive model for recurrence in rectal cancer based on radiological and clinicopathological data.
Eur Radiol
; 31(11): 8586-8596, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33945023
17.
Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.
Oncologist
; 25(3): e502-e511, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162799
18.
Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimens.
BMC Cancer
; 20(1): 633, 2020 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32641104
19.
Regorafenib in patients with advanced Child-Pugh B hepatocellular carcinoma: A multicentre retrospective study.
Liver Int
; 40(10): 2544-2552, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32563213
20.
Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment.
Br J Clin Pharmacol
; 86(9): 1807-1818, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32227355